سعر ثرومبونورم Thrombonorm 0.5 مجم 100 كبسولة 2026
Thrombonorm 0.5mg 100 caps- المادة الفعالة: Anagrelide
- Marcyrl Co.
- عن طريق الفم
- بروشتة طبية
الفئة: خافض للصفائح الدموية
دواعي استعمال ثرومبونورم 0.5
- Thrombocythaemia secondary to myeloproliferative neoplasms, to reduce elevated platelet count and thrombosis risk and ameliorate associated symptoms including thrombo-haemorrhagic events.DailyMed (U.S. National Library of Medicine)
- Thrombocythaemia secondary to myeloproliferative neoplasms, to reduce elevated platelet count and thrombosis risk and ameliorate associated symptoms including thrombo-haemorrhagic events.DailyMed (U.S. National Library of Medicine)
معلومات الدواء
التفاصيل الكاملةعن الدواءAbout the medicine
Anagrelide 0.5 mg oral capsules for thrombocythaemia (platelet-reducing agent), Egyptian product.
Anagrelide 0.5 mg oral capsules for thrombocythaemia (platelet-reducing agent), Egyptian product.
الآثار الجانبيةSide effects
- Most common (>=5%): headache, palpitations, diarrhoea, asthenia, oedema, nausea, abdominal pain, dizziness, pain, dyspnoea, cough, flatulence, vomiting, fever, peripheral oedema, rash, chest pain, anorexia, tachycardia, malaise, paraesthesia, back pain, pruritus, dyspepsia.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Most common (>=5%): headache, palpitations, diarrhoea, asthenia, oedema, nausea, abdominal pain, dizziness, pain, dyspnoea, cough, flatulence, vomiting, fever, peripheral oedema, rash, chest pain, anorexia, tachycardia, malaise, paraesthesia, back pain, pruritus, dyspepsia.International label, same formulation · DailyMed (U.S. National Library of Medicine)
موانع الاستعمالContraindications
- The US label lists no contraindications.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- The US label lists no contraindications.International label, same formulation · DailyMed (U.S. National Library of Medicine)
تحذيرات واحتياطاتWarnings & precautions
- Cardiovascular toxicity: QT prolongation, torsades de pointes and ventricular tachycardia reported; obtain pre-treatment cardiovascular exam including ECG; avoid in patients with QT-prolongation risk factors.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Pulmonary hypertension: assess underlying cardiopulmonary disease before starting.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Bleeding risk, especially with concomitant drugs that cause bleeding.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Cardiovascular toxicity: QT prolongation, torsades de pointes and ventricular tachycardia reported; obtain pre-treatment cardiovascular exam including ECG; avoid in patients with QT-prolongation risk factors.International label, same formulation · DailyMed (U.S. National Library of Medicine)
- Pulmonary hypertension: assess underlying cardiopulmonary disease before starting.International label, same formulation · DailyMed (U.S. National Library of Medicine)
- Bleeding risk, especially with concomitant drugs that cause bleeding.International label, same formulation · DailyMed (U.S. National Library of Medicine)
التداخلات الدوائيةDrug interactions
- QT-prolonging drugs (e.g. amiodarone, methadone, moxifloxacin, haloperidol)Avoid concomitant use.DailyMed (U.S. National Library of Medicine)
- Other PDE3 inhibitors / inotropes (e.g. cilostazol, milrinone)Exacerbation of inotropic effects; avoid.DailyMed (U.S. National Library of Medicine)
- Aspirin and other drugs that increase bleeding riskIncreased risk of bleeding.DailyMed (U.S. National Library of Medicine)
- QT-prolonging drugs (e.g. amiodarone, methadone, moxifloxacin, haloperidol)Avoid concomitant use.DailyMed (U.S. National Library of Medicine)
- Other PDE3 inhibitors / inotropes (e.g. cilostazol, milrinone)Exacerbation of inotropic effects; avoid.DailyMed (U.S. National Library of Medicine)
- Aspirin and other drugs that increase bleeding riskIncreased risk of bleeding.DailyMed (U.S. National Library of Medicine)
الحمل والرضاعةPregnancy & breastfeeding
- Case-report data have not identified a drug-associated risk of major birth defects, miscarriage or adverse outcomes; thrombocythaemia itself carries maternal/fetal risk.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Breastfeeding is not recommended during treatment and for one week after the last dose.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Case-report data have not identified a drug-associated risk of major birth defects, miscarriage or adverse outcomes; thrombocythaemia itself carries maternal/fetal risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
- Breastfeeding is not recommended during treatment and for one week after the last dose.International label, same formulation · DailyMed (U.S. National Library of Medicine)
تابع أسعار الأدوية أول بأول
بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص
المثائل (1)
كل المثائل والبدائلنفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.
| الدواء | السعر | الفرق عن الأصلي |
|---|---|---|
| ماجيسريليد 0.5مجم 10كبسولMagicrelide 0.5 mg capsules (10 capsules)Magic Pharma-Egypt · كبسولات · 0.5 mgالأرخص | السعر50ج.م5ج.م للوحدة | الفرق عن الأصليأرخص 1,520ج.م (96.8%) |
تاريخ السعر
تغيّر السعر الرسمي: من 1,200 إلى 1,570 ج.م، 2 أسعار مسجلة
| التاريخ | السعر (ج.م) |
|---|---|
| سعر سابق بدون تاريخ | 1,200 |
| 1,570 |
| التاريخ | من | إلى | التغيير |
|---|---|---|---|
| 1,200ج.م | 1,570ج.م | زيادة 30.8% |
أدوية ذات صلة
منتجات أخرى من Marcyrl Co.
من فئة خافض للصفائح الدموية
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- DailyMed (U.S. National Library of Medicine)
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا